Prostaglandin analogues and phosphodiesterase inhibitors, either alone or as add-on therapy, are effective treatments for vitiligo repigmentation.
The funding will enable the company in conducting Phase II human clinical trials for its potential drug candidate for ...
Patients with vitiligo may significantly improve the effectiveness of a commonly used light therapy — by nearly twofold— by ...
China Medical System Holdings Limited (the “Company”, together with its subsidiaries, the “Group” or “CMS”) is pleased to announce that on September 24, 2024, the New Drug Application (NDA) for ...
Shares of Incyte INCY have risen 12.7% in the past six months against the industry’s decline of 0.5%. The stock has also ...
Multiple Late-Breaking Data Presentations from Incyte’s Dermatology Portfolio will be Featured at the EADV 2024 Congress ...
In addition to vitiligo, Mini also works with cancer survivors, helping to reconstruct areolas post-mastectomy, and individuals with burn scars or surgical marks. Her approach is deeply personal, ...
Vitiligo is a skin condition that’s little understood and it often takes a long time to diagnose, but now a new treatment could help to cure it. It currently affects around 70 million people around ...
When Jordan Emanuel began filming the latest season of Bravo TV’s Summer House: Martha’s Vineyard, she wasn’t sure if she’d ...
The Company is Divesting its Wellness Unit to Create Value for Shareholders and to Focus on Commercialization of its Safety ...
Although laboratory rats and mice are the most common animal models used in biomedical research, research involving chickens ...
VASI is a valid and reliable tool that is responsive to change and has defined thresholds for meaningful improvement for patients with vitiligo.